Sequence Similarity Clusters for the Entities in PDB 3ULV

Entity #1 | Chains: A
Toll-like receptor 3 protein, length: 694 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 4 5 16788
95 % 4 5 13796 Flexibility: Low
Max RMSD: 2.6, Avg RMSD: 1.6
PDBFlex
90 % 4 5 13613
70 % 5 7 9506
50 % 5 7 8848
40 % 5 7 8485
30 % 5 7 7916
Entity #2 | Chains: L
Fab15 light chain protein, length: 214 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 5 6 14156
95 % 182 213 78 Flexibility: Low
Max RMSD: 7.7, Avg RMSD: 2.3
PDBFlex
90 % 460 538 4
70 % 2098 2391 2
50 % 2623 3030 2
40 % 2623 3030 2
30 % 5323 6153 1
Entity #3 | Chains: H
Fab15 heavy chain protein, length: 225 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 2 3 32309
95 % 6 7 12676 Flexibility: Low
Max RMSD: 4.0, Avg RMSD: 1.7
PDBFlex
90 % 6 7 12471
70 % 2540 2928 1
50 % 2664 3079 1
40 % 2664 3079 1
30 % 5324 6153 1
Entity #4 | Chains: C
Fab12 light chain protein, length: 213 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 1 2 49388
95 % 2 3 19918 Flexibility: Medium
Max RMSD: 9.9, Avg RMSD: 6.7
PDBFlex
90 % 80 90 287
70 % 495 605 7
50 % 2624 3030 2
40 % 2624 3030 2
30 % 5325 6153 1
Entity #5 | Chains: D
Fab12 heavy chain protein, length: 226 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 2 3 25946
95 % 2 3 19919 Flexibility: Medium
Max RMSD: 10.3, Avg RMSD: 7.0
PDBFlex
90 % 2 3 19456
70 % 2541 2928 1
50 % 2665 3079 1
40 % 2665 3079 1
30 % 5326 6153 1
Entity #6 | Chains: E
Fab1068 light chain protein, length: 215 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 2 3 15882
95 % 2 3 13797 Flexibility: Low
Max RMSD: 3.3, Avg RMSD: 1.9
PDBFlex
90 % 461 538 4
70 % 2099 2391 2
50 % 2625 3030 2
40 % 2625 3030 2
30 % 5327 6153 1
Entity #7 | Chains: F
Fab1068 heavy chain protein, length: 223 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 1 2 49389
95 % 2 3 13906 Flexibility: Low
Max RMSD: 4.2, Avg RMSD: 2.6
PDBFlex
90 % 2 3 13718
70 % 2542 2928 1
50 % 2666 3079 1
40 % 2666 3079 1
30 % 5328 6153 1

Instructions

In the table for each entity, view a list of similar sequences by selecting the link associated with the percentage cutoff.



View more detailed documentation on the redundancy reduction and sequence clustering procedure used by RCSB PDB.

You can also use the structure comparison tool to compare any 2 given structures


ACTION - (A) Select for download / view details OR (B) Select two chains for comparison
Rank PDB ID Entity ID Chains Description Details Taxonomy EC Number
1 4NZU 1 L 13PL heavy chain Fab 9606
2 4NZU 2 H 13PL light chain Fab 9606
3 1MJU 1 L IMMUNOGLOBULIN MS6-12 Fab fragment, LIGHT CHAIN 10090
4 1MJU 2 H IMMUNOGLOBULIN MS6-12 Fab fragment, HEAVY CHAIN 10090
5 4TRP 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
6 4TRP 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
7 1MEX 1 L Fab 29G12 light chain 10090
8 1MEX 2 H Fab 29G12 heavy chain 10090
9 3D9A 2 L Light Chain of HyHel10 Antibody Fragment (Fab) 10090
10 3D9A 3 H Heavy Chain of HyHel10 Antibody Fragment (Fab) 10090
11 4BUH 1 A, B CLONE M0418 SCFV 9606
12 3TV3 1 L PGT128 light chain, Ig lambda-2 chain C regions PGT128 light chain 9606
13 3TV3 2 H PGT128 heavy chain, Ig gamma-1 chain C region PGT128 heavy chain 9606
14 1NCW 1 L IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, light chain 10090
15 1NCW 2 H IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, heavy chain 10090
16 5YD4 1 A, C, E, G scFv 4B08 10090
17 5YD3 1 A, C, E, G scFv 4B08 10090
18 5UD9 1 H Fab heavy chain 9606
19 5UD9 2 L Light chain 9606
20 4P48 1 A Antibody scFv 180 9031
21 6DDM 1 A Anti-MICA Fab fragment light chain clone 1D5 10090
22 6DDM 3 B Anti-MICA Fab fragment heavy chain clone 1D5 10090
23 5TY6 1 H VRC 315 13-1b02 Fab Heavy chain 9606
24 5TY6 2 L VRC 315 13-1b02 Fab Light chain 9606
25 2XZC 1 H FAB A.17 HEAVY CHAIN 9606
26 2XZC 2 L FAB A.17 LIGHT CHAIN 9606
27 2XKN 1 A, C ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT LIGHT CHAIN (IGG1), RESIDUES 1-223 10090
28 2XKN 2 B, D ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT HEAVY CHAIN (IGG1), RESIDUES 1-216 10090
29 6MEE 1 A, C antibody HEPC74 Heavy Chain 9606
30 6MEE 2 B, D antibody HEPC74 Light Chain 9606
31 6BJZ 1 H 5c8 Fab Heavy chain 9606
32 6BJZ 2 L 5c8 Fab Light chain 9606
33 5KVG 2 L ZV-67 Antibody Fab Light Chain 10090
34 5KVG 3 H ZV-67 Antibody Fab Heavy Chain 10090
35 5WCA 1 H VRC315 27-1C08 Fab Heavy chain 9606
36 5WCA 2 L VRC315 27-1C08 Fab Light chain 9606
37 4XCF 1 L 4E10 Fab light chain 9606
38 4XCF 2 H 4E10 Fab heavy chain 9606
39 5KVF 2 L ZV-64 Antibody Fab Light Chain 10090
40 5KVF 3 H ZV-64 Antibody Fab Heavy Chain 10090
41 1RUP 1 L immunoglobulin igg2a, heavy chain fab 10090
42 1RUP 2 H immunoglobulin igg2a, light chain fab 10090
43 3ESU 1 F Antibody 14b7* light chain and antibody 14b7* heavy chain linked with a synthetic (GGGGS)4 linker 10090
44 1RUK 1 L immunoglobulin igg2a, light chain fab 10090
45 1RUK 2 H immunoglobulin igg2a, heavy chain fab 10090
46 5VXR 1 H MAb24 Variable Heavy Chain,MAb24 Variable Heavy Chain 10090
47 5VXR 2 L MAb24 Variable Light Chain,MAb24 Variable Light Chain 10090
48 5X08 1 H Fab 4E10 Heavy chain 9606
49 5X08 2 L Fab 4E10 Light chain 9606
50 6NB8 1 H S230 antigen-binding (Fab) fragment, heavy chain 9606
51 6NB8 2 L S230 antigen-binding (Fab) fragment, light chain 9606
52 6A76 1 L Light chain of the anti-human Robo1 antibody B5209B Fab 10090
53 6A76 2 H Heavy chain of the anti-human Robo1 antibody B5209B Fab 10090
54 6U1T 1 H antigen-binding (Fab) fragment, heavy chain 10090
55 6U1T 2 L antigen-binding (Fab) fragment, light chain 10090
56 6MEG 1 H antibody HEPC46 Heavy Chain 9606
57 6MEG 2 L antibody HEPC46 Light Chain 9606
58 4XAW 1 L 4E10 Fab light chain 9606
59 4XAW 2 H 4E10 Fab heavy chain 9606
60 4P49 1 A Antibody scFv B8 9031
61 3N9G 1 H Fab fragment of MAb CR4354, heavy chain 9606
62 3N9G 2 L Fab fragment of MAb CR4354, light chain 9606
63 4TUL 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
64 4TUL 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
65 5UCB 1 H Fab Heavy Chain 9606
66 5UCB 2 L Fab Light Chain 9606
67 2VXV 1 H HUMAN IGG ABT-325 9606
68 2VXV 2 L HUMAN IGG ABT-325 9606
69 6QF9 1 A, B scFv 9606
70 6FRJ 1 H scFv-SM3 Although this structure is a ScFv, please follow the same numbering as shown in PDB entry 5OWP. 10090
71 4GXV 1 H, I Antibody 1F1, heavy chain 9606
72 4GXV 2 L, M Antibody 1F1, light chain 9606
73 2VXT 1 H MURINE IGG 125-2H 10090
74 2VXT 3 L MURINE IGG 125-2H 10090
75 6CR1 1 L Light chain of adalimumab EFab (VL-IgE CH2) 9606
76 6CR1 2 H Heavy chain of adalimumab EFab (VH-IgE CH2) 9606
77 1RUM 1 L immunoglobulin igg2a, light chain fab 10090
78 1RUM 2 H immunoglobulin igg2a, heavy chain fab 10090
79 2XZA 1 H FAB A.17 HEAVY CHAIN 9606
80 2XZA 2 L FAB A.17 LIGHT CHAIN 9606
81 2W60 1 A ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
82 2W60 2 B ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
83 5W24 1 L 5C4 Fab Light Chain 10090
84 5W24 2 H 5C4 Fab Heavy Chain 10090
85 4HPY 1 H CH59 Fab heavy chain 9606
86 4HPY 2 L CH59 Fab light chain 9606
87 3T65 1 B S25-2 FAB (IGG1K) heavy chain 10090
88 3T65 2 A S25-2 FAB (IGG1K) light chain 10090
89 5C6W 1 H, J Protein IGHV1-69-2,Ig lambda chain V-II region NIG-84 9606
90 4JG1 1 L Fab light chain 9606
91 4JG1 2 H Fab heavy chain 9606
92 6E65 1 L TB31F Fab light chain 9606
93 6E65 2 H TB31F Fab heavy chain 9606
94 3M8O 1 L IMMUNOGLOBULIN A1 LIGHT CHAIN Fab fragment 9606
95 3M8O 2 H IMMUNOGLOBULIN A1 HEAVY CHAIN Fab fragment 9606
96 5VF2 1 A scFv 2D10 10090
97 5I8C 1 A VRC34.01 Fab heavy chain 9606
98 5I8C 2 B VRC34.01 Fab light chain 9606
99 4O5L 1 L Fab F045-092 light chain 9606
100 4O5L 2 H Fab F045-092 heavy chain 9606
101 5MYX 1 A, C Fab c#24 light chain 10090
102 5MYX 2 B, D Fab c#24 heavy chain Pyroglutamate residue 1 (PCA) results from post-translational modification of original residue glutamine 1. 10090
103 3IFL 1 L 12A11 FAB antibody light chain 10090
104 3IFL 2 H 12A11 FAB antibody heavy chain 10090
105 5WK2 1 L M116 LIGHT CHAIN 9606
106 5WK2 2 H M116 HEAVY CHAIN FD 9606
107 3PP4 1 H GA101 Fab heavy chain 10090
108 3PP4 2 L GA101 Fab light chain 10090
109 3KDM 1 A, L Immunoglobulin light chain 9606
110 3KDM 2 B, H Immunoglobulin heavy chain 9606
111 5NIV 1 A Light chain of 5D3 Fab 10090
112 5NIV 2 B Heavy chain of 5D3 Fab 10090
113 5N4J 1 L LIGHT CHAIN 9606
114 5N4J 2 H HEAVY CHAIN the sequence provided include the cleavable tag 9606
115 2AJU 1 L ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
116 2AJU 2 H ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
117 2AJV 1 L Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
118 2AJV 2 H Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
119 5X4G 1 A 6H8 Fab heavy chain 10090
120 5X4G 2 B 6H8 Fab light chain 10090
121 3SY0 1 A S25-2 FAB (IGG1K) light chain 10090
122 3SY0 2 B S25-2 FAB (IGG1K) heavy chain 10090
123 4PTU 1 A Antibody pn132p2C05, light chain 9606
124 4PTU 2 B Antibody pn132p2C05, heavy chain 9606
125 4TPR 1 L If kappa light chain 10090
126 4TPR 2 H Fab heavy chain 10090
127 4HS6 2 A, L MRCT10.v362 Fab light chain 9606
128 4HS6 3 B, H MRCT10.v362 Fab heavy chain 9606
129 3IFN 1 H 12A11 FAB antibody heavy chain 10090
130 3IFN 2 L 12A11 FAB antibody light chain 10090
131 5U3P 1 H DH511.4 Fab Heavy Chain 9606
132 5U3P 2 L DH511.4 Fab Light Chain 9606
133 6BLA 1 H AMM01 Fab Heavy chain 9606
134 6BLA 2 L AMM01 Fab Light chain 9606
135 4TOY 1 H 35O22 Fab Heavy chain 9606
136 4TOY 2 L 35O22 Fab Light chain 9606
137 4TUO 1 A, C Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
138 4TUO 2 B, D Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
139 3NPS 2 B S4 FAB HEAVY CHAIN 9606
140 3NPS 3 C S4 FAB LIGHT CHAIN 9606
141 5I4F 1 A scFv 2D10 10090
142 1RUR 1 L immunoglobulin 13G5, light chain fab 10090
143 1RUR 2 H immunoglobulin 13G5, heavy chain fab 10090
144 5ADO 1 H FAB A.17 HEAVY CHAIN 9606
145 5ADO 2 L FAB A.17 LIGHT CHAIN 9606
146 5WN9 1 H scFv 2D10 9606
147 4XC3 1 L 4E10 Fab light chain 9606
148 4XC3 2 H 4E10 Fab heavy chain 9606
149 1X9Q 1 A 4m5.3 anti-fluorescein single chain antibody fragment antibody binding fragment 9606
150 4M5Y 1 H, I Fab 5J8 heavy chain 9606
151 4M5Y 2 L, M Fab 5J8 light chain 9606
152 4TQE 1 L If kappa light chain 10090
153 4TQE 2 H Fab heavy chain 10090
154 5YY4 1 A scFv 4B08 10090
155 4ISV 1 A 1C2 FAB LIGHT CHAIN 10090
156 4ISV 2 B 1C2 FAB HEAVY CHAIN 10090
157 4XC1 1 L 4E10 FAB LIGHT CHAIN 9606
158 4XC1 2 H 4E10 FAB HEAVY CHAIN 9606
159 5VSI 1 H CH1/Ckappa Fab heavy chain 9606
160 5VSI 2 L CH1/Ckappa Fab light chain 9606
161 5ODB 1 A D10 Fab fragment - heavy chain not modeled residues are not visible in the electron density map the Fab fragment was prepared from a antibody chimera containing the variable domains of the human D10 mAb and the constant domains of mouse IgG2a heavy chain and Ig-lambda light chain 9606
162 5ODB 2 B D10 Fab fragment - light chain not modeled residues are not visible in the electron density map the Fab fragment was prepared from a antibody chimera containing the variable domains of the human D10 mAb and the constant domains of mouse IgG2a heavy chain and Ig-lambda light chain 9606
163 4CMH 2 B HEAVY CHAIN OF SAR650984-FAB FRAGMENT 10090
164 4CMH 3 C LIGHT CHAIN OF SAR650984-FAB FRAGMENT 10090
165 5JXA 1 H VRC03 Heavy chain 9606
166 5JXA 2 L VRC03 Light chain 9606
167 3QHZ 1 H, I Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606
168 3QHZ 2 L, M Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606
169 6QCU 1 L Light chain 9606
170 6QCU 2 H Heavy chain 9606
171 3UJI 1 L Light chain of anti-HIV-1 V3 monoclonal antibody 2558 9606
172 3UJI 2 H Fab region of the heavy chain of anti-HIV-1 V3 monoclonal antibody 2558 9606
173 3NTC 1 L Fab light chain 10090
174 3NTC 2 H Fab heavy chain 10090
175 4YNY 1 A, C Heavy chain of antigen binding fragment, Fab 10116
176 4YNY 2 B, D Light chain of antigen binding fragment, Fab 10116
177 4TUK 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
178 4TUK 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
179 4YO0 1 A, C Heavy chain of antigen binding fragment, Fab 10116
180 4YO0 2 B, D Light chain of antigen binding fragment, Fab 10116
181 6AZM 1 A, C 580 germline antibody, light chain Fragment: Fab 9606
182 6AZM 2 B, D 580 germline antibody, heavy chain Fragment: Fab 9606
183 6BE3 1 H Fab (F598) Heavy Chain 9606
184 6BE3 2 L Fab (F598) Light Chain 9606
185 4NWU 1 H APE1551 Ab Fab heavy chain 9606
186 4NWU 2 L APE1551 Ab Fab light chain 9606
187 3HC4 1 H IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
188 3HC4 2 L IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
189 5VZR 1 A, H G4 antibody heavy chain Fab fragment 10090
190 5VZR 2 B, L G4 antibody light chain Fab fragment 10090
191 2W9D 1 H ICSM 18-ANTI-PRP THERAPEUTIC FAB HEAVY CHAIN 10090
192 2W9D 2 L ICSM 18-ANTI-PRP THERAPEUTIC FAB LIGHT CHAIN 10090
193 5EWI 1 H VRC38.01 Heavy Chain 9606
194 5EWI 2 L VRC38.01 Light Chain 9606
195 5E2W 1 L AT8 LIGHT CHAIN 10090
196 5E2W 2 H AT8 HEAVY CHAIN 10090
197 5MYK 1 A Fab c#17 light chain 10090
198 5MYK 2 B Fab c#17 heavy chain 10090
199 4NZR 1 H PGT135 heavy chain Fab 9606
200 4NZR 2 L PGT135 light chain Fab 9606
201 5MYO 1 A, C Fab c#6 light chain 10090
202 5MYO 2 B, D Fab c#6 heavy chain 10090
203 4HBC 1 H Antigen Binding Fragment, Immunoglobulin IgG - Heavy Chain 9986
204 4HBC 2 L Antigen Binding Fragment, Immunoglobulin IgG - Light Chain 9986
205 4AEH 1 H FAB ANTIBODY, HEAVY CHAIN VARIABLE DOMAIN, RESIDUES 1-231 10090
206 4AEH 2 L FAB ANTIBODY, LIGHT CHAIN VARIABLE DOMAIN, RESIDUES 1-214 10090
207 5UEL 1 H 354NC102 Fab Heavy Chain 9606
208 5UEL 2 L 354NC102 Fab Light Chain 9606
209 3UZQ 1 A anti-dengue Mab 4E11 Single chain variable fragment 10090
210 2V17 2 H MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
211 2V17 3 L MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
212 4J6R 2 H HEAVY CHAIN OF ANTIBODY VRC23 9606
213 4J6R 3 L LIGHT CHAIN OF ANTIBODY VRC23 9606
214 5E2V 1 L AT8 LIGHT CHAIN 10090
215 5E2V 2 H AT8 HEAVY CHAIN 10090
216 5SY8 1 H 10E8 FAB HEAVY CHAIN 9606
217 5SY8 2 L 10E8 FAB LIGHT CHAIN 9606
218 5OCK 1 L Human ACPA E4 Fab fragment - Light chain the N-terminal glutamine is posttranslationally modified to pyroglutamic acid 9606
219 5OCK 2 H Human ACPA E4 Fab fragment - Heavy chain the N-terminal glutamine is posttranslationally modified to pyroglutamic acid 9606
220 5DD1 1 H ANTI-HIV ANTIBODY DH570 FAB HEAVY CHAIN 9544
221 5DD1 2 L ANTI-HIV ANTIBODY DH570 FAB LIGHT CHAIN 9544
222 5JUE 1 L light chain of UIC2 Fab 10090
223 5JUE 2 H heavy chain of UIC2 Fab 10090
224 5CIN 1 H FAB 4E10 HEAVY CHAIN 9606
225 5CIN 2 L FAB 4E10 LIGHT CHAIN 9606
226 5A2J 1 H SCFV-SM3 CONTAINS BOTH H AND L CHAINS OF SCFV-SM3, CONNECTEDBY A LINKER. CHAIN L RESIDUES ARE NUMBERED FROM 1000. RESIDUES 6-115,20-129 10090
227 5JR1 1 H 10E8 heavy chain 9606
228 5JR1 2 L 10E8 mature light chain 9606
229 6CA7 1 L PCT64_13C light chain 9606
230 6CA7 2 H PCT64_13C heavy chain 9606
231 5VF6 1 A single chain variable fragment 9031
232 3CFB 1 A, L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
233 3CFB 2 B, H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090
234 3WII 1 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
235 3WII 2 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090
236 6K4Z 1 A, B scFv of C6 The fusion protein of expression tags (residues -2-0), the light chain (residues 1-108), linker GGGGSGGGGSGGGGS (residues 501-515), and the heavy chain (residues 1001-1113) 10090
237 6MVL 2 H Antibody Fab fragment heavy chain 9606
238 6MVL 3 L Antibody Fab fragment light chain 9606
239 5OB5 2 H fAb Heavy chain 9606
240 5OB5 3 L fAb Light chain 9606
241 3BKJ 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
242 3BKJ 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
243 5I66 1 A 8B6 antibody, heavy chain 10090
244 5I66 2 B 8B6 antibody, light chain 10090
245 6QBC 1 H Anti-Mcl1 Fab Heavy Chain 9606
246 6QBC 2 L Anti-Mcl1 Fab Light Chain 9606
247 4JAM 1 A, H ANTIGEN BINDING FRAGMENT OF HEAVY CHAIN of CH103 9606
248 4JAM 2 B, L ANTIGEN BINDING FRAGMENT OF LIGHT CHAIN of CH103 9606
249 6BZY 1 H 22D11 Heavy Chain 10090
250 6BZY 2 L 22D11 Light Chain 10090
251 3QQ9 1 C, L 101F LIGHT CHAIN 10090
252 3QQ9 2 D, H 101F HEAVY CHAIN 10090
253 5TKK 2 H mouse antibody vFP5.01 heavy chain 10090
254 5TKK 3 L mouse antibody vFP5.01 light chain 10090
255 5FGB 1 A, B Anti-HCV E2 Fab HC84-1 light chain 9606
256 5FGB 2 C, E Anti-HCV E2 Fab HC84-1 heavy chain 9606
257 5W6C 1 H UCA Fab heavy chain 9606
258 5W6C 2 L UCA Fab light chain 9606
259 5I1K 1 L FAB LIGHT CHAIN 9606
260 5I1K 2 H FAB HEAVY CHAIN 9606
261 3OZ9 1 L Fab NC-1 kappa light chain 10090
262 3OZ9 2 H Fab NC-1 IgG2a heavy chain 10090
263 4JDV 1 A, H Fab heavy chain NIH45-46 Germ-line HEAVY CHAIN, IG GAMMA-1 CHAIN 9606
264 4JDV 2 B, L Fab light chain NIH45-46 Germ-line Light CHAIN, IG Kappa 9606
265 5V7U 1 L CBTAU-22.1 Fab light chain 9606
266 5V7U 2 H CBTAU-22.1 Fab heavy chain 9606
267 5UEA 1 A, H Fab Heavy Chain 9606
268 5UEA 3 B, L Fab Light Chain 9606
269 4AL8 2 H FAB 2H12 HEAVY CHAIN 9606
270 4AL8 3 L FAB 2H12 LIGHT CHAIN 9606
271 3G5Y 1 A 175 light chain 10090
272 3G5Y 2 B 175 heavy chain 10090
273 5NMV 1 L Fab light chain 10088
274 5NMV 2 H Fab heavy chain 10088
275 4N8C 1 H, I Heavy chain of monoclonal antibody 10090
276 4N8C 2 L, M Light chain of monoclonal antibody 10090
277 5AZ2 1 H anti-human epiregulin antibody 9E5 Fab heavy chain 10090
278 5AZ2 2 L anti-human epiregulin antibody 9E5 Fab light chain 10090
279 4HGW 1 A Antibody Fab fragment, light chain 10090
280 4HGW 2 B Antibody Fab fragment, heavy chain 10090
281 1NLB 1 L antibody 19D9D6 light chain 10090
282 1NLB 2 H antibody 19D9D6 heavy chain 10090
283 1C5C 1 L CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 103-214) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-102) IS FROM MURINE SOURCE FAB 10090
284 1C5C 2 H CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 109-230) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-108) IS FROM MURINE SOURCE FAB 10090
285 3VFG 1 L 3F8 Light Chain 10090
286 3VFG 2 H 3F8 Heavy Chain 10090
287 5TDN 1 A, C anti-HER2 Fab Light Chain 9606
288 5TDN 2 B, D anti-HER2 Fab Heavy Chain 9606
289 3QRG 1 L Fab light chain 9606
290 3QRG 2 H Fab heavy chain Fd fragment 9606
291 5M6A 1 A, B, C, D Bence-Jones light chain 9606
292 4LLY 1 A, C mutated Pertuzumab Fab heavy chain 9606
293 4LLY 2 B, D light chain Clambda 9606
294 4EBQ 1 H anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, heavy chain Fab 10090
295 4EBQ 2 L anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, light chain 10090
296 5EZI 1 H Fab c12 heavy chain 9606
297 5EZI 2 L Fab c12 Light chain 9606
298 4K23 1 H anti-uPAR antibody, heavy chain 10090
299 4K23 2 L anti-uPAR antibody, light chain 10090
300 3NCJ 1 L Fab15 Mut8 light chain 9606
301 3NCJ 2 H Fab15 Mut8 heavy chain 9606
302 3UO1 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
303 3UO1 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
304 4M1G 1 L Murine IgG2a A27D7 Light chain Fab domain 10090
305 4M1G 2 H Murine IgG2a A27D7 Heavy chain Fab domain 10090
306 5W05 1 L M59 FAB LIGHT CHAIN 10090
307 5W05 2 H M59 FAB HEAVY CHAIN FD 10090
308 2IPU 1 K, L IgG2a Fab fragment Heavy Chain 10090
309 2IPU 2 G, H IgG2a Fab fragment Light Chain Kappa 10090
310 3HC3 1 H IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
311 3HC3 2 L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
312 4M61 1 A, C Fab A52 light chain 10090
313 4M61 2 B, D Fab A52 heavy chain 10090
314 5YE3 1 B 2A7D9 VH CH1 chain 10090
315 5YE3 2 A 2A7D9 L chain 10090
316 3BKM 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
317 3BKM 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
318 1UM5 1 L Antibody 21H3 L chain 10090
319 1UM5 2 H Antibody 21H3 H chain 10090
320 3QHF 1 H Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606
321 3QHF 2 L Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606
322 4NWT 1 L APE1531 Ab Fab light chain 9606
323 4NWT 2 H APE1531 Ab Fab heavy chain 9606
324 3WHX 1 A mAb Fab H fragment 10090
325 3WHX 2 B mAb Fab L fragment 10090
326 3NA9 1 L Fab15 light chain 9606
327 3NA9 2 H Fab15 heavy chain 9606
328 3BAE 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
329 3BAE 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
330 6RCO 1 A, C R5.004 heavy chain 9606
331 6RCO 2 B, D R5.004 light chain 9606
332 1NGZ 1 A Germline Metal Chelatase Catalytic Antibody, Light chain germline Fab fragment 10090
333 1NGZ 2 B Germline Metal Chelatase Catalytic Antibody, Heavy chain germline Fab fragment 10090
334 4LRI 1 A, B MSL-109 Light Chain 9606
335 4LRI 2 C, P MSL-109 Heavy Chain 9606
336 4ZTP 1 L Light chain of Fab fragment of rabbit monoclonal antibody R53 9986
337 4ZTP 2 H Heavy chain of Fab fragment of rabbit monoclonal antibody R53 9986
338 4JN2 1 A, L anti dabigatran Fab 10090
339 4JN2 2 B, H anti dabigatran Fab 10090
340 4XBE 1 L 4E10 FAB LIGHT CHAIN 9606
341 4XBE 2 H 4E10 Fab heavy chain 9606
342 1MJ8 1 L IMMUNOGLOBULIN MS6-126 Fab Fragment, LIGHT CHAIN 10090
343 1MJ8 2 H IMMUNOGLOBULIN MS6-126 Fab Fragment, HEAVY CHAIN 10090
344 6BE2 1 H Fab (F598) Heavy Chain 9606
345 6BE2 2 L Fab (F598) Light Chain 9606
346 4JFZ 1 L Fab light chain 9606
347 4JFZ 2 H Fab heavy chain 9606
348 6ARP 1 A, C Cetuximab mutant light chain,Uncharacterized protein 9606
349 6ARP 2 B, D Cetuximab mutant Fab heavy chain,Immunoglobulin gamma-1 heavy chain 9606
350 3WIF 1 A mAb Fab H fragment 10090
351 3WIF 2 B mAb Fab L fragment 10090
352 5U6A 1 A Light Chain 9606
353 5U6A 2 B Heavy Chain 9606
354 5KVD 2 L ZV-2 Antibody Fab Light Chain 10090
355 5KVD 3 H ZV-2 Antibody Fab Heavy Chain 10090
356 3MBX 1 L X836 LIGHT CHAIN 10090
357 3MBX 2 H X836 HEAVY CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN, FD fragment 10090
358 3TWC 1 L PGT127 light chain, Ig lambda-2 chain C regions 9606
359 3TWC 2 H PGT127 heavy chain, Ig gamma-1 chain C region 9606
360 6APC 1 H Epididymis luminal protein 214 9606
361 6APC 2 L IGL@ protein 9606
362 4HHA 1 A Fab KE5 Fab fragment KE5 9606
363 4HHA 2 B Antibody KE5 AD-2S1 eptiope 9606
364 6FZQ 1 H scFv-1SM3,scFv-1SM3 10090
365 5A2K 1 H IG LAMBDA-1 CHAIN V REGION S43 RESIDUES 6-115,20-129 10090
366 4RGO 2 H 14G8 heavy chain Fab 10090
367 4RGO 3 L 14G8 light chain Fab 10090
368 5N7B 1 H Ig heavy chain V-III region J606,Ig lambda-1 chain V region S43 Please follow the numbering described in the PDB entry 5A2K 10090
369 5GRY 1 A, G diabody 9606
370 5UEK 2 H Fab 12E Heavy Chain 9606
371 5UEK 3 L Fab 12E Light Chain 9606
372 3NAA 1 L Fab15 Mut5 light chain 9606
373 3NAA 2 H Fab15 Mut5 heavy chain 9606
374 1Q0X 1 L Fab 9B1, light chain 10090
375 1Q0X 2 H Fab 9B1, heavy chain 10090
376 4R90 1 L Anti CD70 Llama glama Fab 27B3 Light chain 9844
377 4R90 2 H Anti CD70 Llama glama Fab 27B3 Heavy chain 9844
378 4XVT 2 H donor 45 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Heavy chain 9606
379 4XVT 3 L 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Light chain 9606
380 5IK3 1 A, C 1E03 Fab fragment heavy chain 9606
381 5IK3 2 B, D 1E03 Fab fragment light chain 9606
382 5NPH 2 H Heavy chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
383 5NPH 3 L Light chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
384 5XLI 1 a, b FabL 10090
385 5XLI 2 c, d FabH 10090
386 5IHZ 1 A, C, E, H 1E01 Fab fragment heavy chain 9606
387 5IHZ 2 B, D, F, L 1E01 Fab fragment light chain 9606
388 6DC4 1 H Fab AM22 Heavy Chain 9606
389 6DC4 2 L Fab AM22 Light Chain 9606
390 2R1X 1 A Fab, antibody fragment (IgG1k), light chain 10090
391 2R1X 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
392 5U3D 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
393 5U3D 2 B MEMAB TRASTUZUMAB FAB HEAVY CHAIN 9606
394 4WUK 1 H CH65 heavy chain 9606
395 4WUK 2 L CH65 light chain 9606
396 3MLY 1 L, M Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab light chain 9606
397 3MLY 2 H, I Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab heavy chain 9606
398 5U3O 1 H DH511.2_K3 Fab Heavy Chain 9606
399 5U3O 2 L DH511.2_K3 Fab Light Chain 9606
400 5JOP 1 D, L Fab 14.22 light chain 10090
401 5JOP 2 E, H Fab14.22 heavy chain 10090
402 4HPO 1 H CH58 Fab heavy chain 9606
403 4HPO 2 L CH58 Fab light chain 9606
404 5UKN 1 H DH522UCA Fab fragment heavy chain 9544
405 5UKN 2 L DH522UCA Fab fragment light chain 9544
406 6BHZ 1 H, I Trastuzumab Anti-HER2 Fab Heavy Chain 9606
407 6BHZ 2 L, M Trastuzumab Anti-HER2 Fab Light Chain D185A 9606
408 5IT2 1 H heavy chain 9606
409 5IT2 2 L light chain 9606
410 6MY4 1 A, H anti-VEGF-A Fab fragment bH1 heavy chain 9606
411 6MY4 2 B, L anti-VEGF-A Fab fragment bH1 light chain 9606
412 4POZ 1 C light chain of Fab fragment of 10B9 antibody 10090
413 4POZ 2 D heavy chain of Fab fragment of 10B9 antibody 10090
414 4F57 1 L Light chain of Fab of a neutralizing antibody L1 light chain of L1 9606
415 4F57 2 H Heavy chain of Fab of a neutralizing antibody L1 heavy chain of L1 9606
416 5MO3 2 H Fab of monoclonal antibody, heavy chain 10090
417 5MO3 3 L Fab of monoclonal antibody, light chain 10090
418 5GZ0 1 A, C FM329 light chain 1383439
419 5GZ0 2 B, D FM329 heavy chain 1383439
420 6DW2 1 A 6078 Fab light chain 9606
421 6DW2 2 B 6078 Fab heavy chain 9606
422 6MG4 1 A, B JTO light chain 9606
423 6BQB 1 L MGG4 Fab light chain 9606
424 6BQB 2 H MGG4 Fab heavy chain 9606
425 4PUB 1 H DX-2930 HEAVY CHAIN 9606
426 4PUB 2 L DX-2930 LIGHT CHAIN 9606
427 6B14 1 H Heavy chain of Fab BL3-6S97N 10090
428 6B14 2 L Light chain of Fab BL3-6S97N 10090
429 5DD6 1 A, H ANTI-HIV ANTIBODY DH570.mut58 FAB HEAVY CHAIN 9544
430 5DD6 2 B, L ANTI-HIV ANTIBODY DH570.mut58 FAB LIGHT CHAIN 9544
431 3WIH 2 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
432 3WIH 3 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090
433 5GS3 1 A, H diabody protein 9606
434 3CFC 1 H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090
435 3CFC 2 L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
436 3V4U 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
437 3V4U 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
438 5VKD 2 H Fab Heavy Chain 9606
439 5VKD 3 L Fab light chain 9606
440 2R1Y 1 A Fab, antibody fragment (IgG1k), light chain 10090
441 2R1Y 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
442 5XHG 1 A, C polypeptide(L) 10090
443 5XHG 2 B, D polypeptide(H) 10090
444 4XMP 2 H HEAVY CHAIN OF ANTIBODY VRC08 9606
445 4XMP 3 L LIGHT CHAIN OF ANTIBODY VRC08 9606
446 3UYR 1 H antibody Fab heavy chain 10090
447 3UYR 2 L antibody Fab light chain 10090
448 3V0W 1 L WN1 222-5 Fab (IgG2a) light chain 10090
449 3V0W 2 H WN1 222-5 Fab (IgG2a) heavy chain 10090
450 5OCX 1 L Fab fragment anti-citrullinated protein antibody E4 - light chain N-terminal glutamine is posttranslationally modified to pyroglutamic acid produced as chimera of human E4 mAb variable domains and mouse IgG2a constant domains 9606
451 5OCX 2 H Fab fragment of anti-citrullinated protein antibody E4 - heavy chain unmodelled residues not visible in electron density produced as chimera of human mAb E4 variable domains and mouse IgG2a constant domains 9606
452 1YQV 1 L HyHEL-5 Antibody Light Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
453 1YQV 2 H HyHEL-5 Antibody Heavy Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
454 3OAZ 1 H, M Fab 2G12, heavy chain Fab 9606
455 3OAZ 2 K, L Fab 2G12, light chain 9606
456 2R2B 1 A Fab, antibody fragment (IgG1k), light chain 10090
457 2R2B 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
458 1ZAN 1 L Fab AD11 Light Chain 10116
459 1ZAN 2 H Fab AD11 Heavy Chain 10116
460 6CJK 1 A, C Immunoglobulin Fab light chain 9986
461 6CJK 2 B, D Immunoglobulin Fab heavy chain 9986
462 4N0Y 1 H IGH526 Heavy Chain 9606
463 4N0Y 2 L IGH526 Light Chain 9606
464 3V52 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
465 3V52 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
466 6OTC 2 H sFab H3 heavy chain 32630
467 6OTC 3 L sFab H3 light chain 32630
468 5MTH 1 A, H antibody Fab heavy chain 10090
469 5MTH 2 B, L antibody Fab light chain 10090
470 3GGW 1 A, C FAB F22-4 LIGHT CHAIN 10090
471 3GGW 2 B, D FAB F22-4 HEAVY CHAIN 10090
472 1RZF 1 L Fab E51 light chain 9606
473 1RZF 2 H Fab E51 heavy chain 9606
474 5ZMJ 1 H Heavy chain of a Fab fraction of human IgG P01857 (UniProt) is referred. 9606
475 5ZMJ 2 L Light chain of a Fab fraction of human IgG P0DOY2(UniProt) is referred. 9606
476 6MY5 1 A, H anti-VEGF-A Fab fragment bH1 heavy chain 9606
477 6MY5 2 B, L anti-VEGF-A Fab fragment bH1 light chain 9606
478 4KTE 1 H GE148 Heavy Chain Fab Fab fragment 9544
479 4KTE 2 L GE148 Light Chain Fab 9544
480 5I8O 1 H HMM5 antibody heavy chain 9606
481 5I8O 2 L HMM5 antibody light chain 9606
482 4OUO 1 A anti Bla g 1 scFv 9031
483 4JG0 1 L Fab light chain 9606
484 4JG0 2 H Fab heavy chain 9606
485 4YGV 1 A, F aDabi-Fab2a heavy chain 9606
486 4YGV 2 B, L aDabi-Fab2a light chain 9606
487 5U4R 1 A, H VRC 315 53-1A09 Fab Heavy chain 9606
488 5U4R 2 B, L VRC 315 53-1A09 Fab Light chain 9606
489 5ALC 1 H ANTI-TICAGRELOR FAB 72, HEAVY CHAIN 9606
490 5ALC 2 L ANTI-TICAGRELOR FAB 72, LIGHT CHAIN 9606
491 5U5F 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
492 5U5F 2 B MEMAB TRASTUZUMAB FAB HEAVY CHAIN 9606
493 3EO0 1 A, C GC-1008 Fab Light Chain 10090
494 3EO0 2 B, D GC-1008 Fab Heavy Chain 10090
495 5CIL 1 H FAB 4E10 HEAVY CHAIN 9606
496 5CIL 2 L FAB 4E10 LIGHT CHAIN 9606
497 6BI2 1 H, I Trastuzumab Anti-HER2 Fab Heavy Chain 9606
498 6BI2 2 L, M Trastuzumab Anti-HER2 Fab Light Chain 9606
499 5F3B 1 A, E RK35 Chimeric antibody heavy chain 10090
500 5F3B 2 B, F RK35 Chimeric antibody light chain 10090
501 4FQI 3 H antibody CR9114 heavy chain Fab 9606
502 4FQI 4 L antibody CR9114 light chain Fab Lambda 9606
503 6S5A 2 H anti P329G LALA Fab heavy chain 10090
504 6S5A 3 L anti P329G LALA Fab light chain 10090
505 4JHA 1 H D25 antigen-binding fragment heavy chain 9606
506 4JHA 2 L D25 light chain 9606
507 6B9Z 1 A Trastuzumab Fab light chain 10090
508 6B9Z 2 B Trastuzumab Fab heavy chain CSO is partially oxidized cysteine 10090
509 3MCL 1 L C706 MONOCLONAL LIGHT CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
510 3MCL 2 H C706 MONOCLONAL HEAVY CHAIN FD fragment of the heavy chain, CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
511 4PTT 1 A Antibody pn132p2C05, light chain 9606
512 4PTT 2 B Antibody pn132p2C05, heavy chain 9606
513 5OD0 1 L Fab fragment of ACPA E4 - Light chain the Fab fragment was prepared from a chimeric antibody containing the variable domain of human ACPA E4 and constant domains of mouse IgG2b the N-terminal Gln is posttranslationally modified to pyroglutamic acid 2 C-terminal residues not visible in electron density and therefore not modelled 9606
514 5OD0 2 H Fab fragment of ACPA E4 - heavy chain the Fab fragment was prepared from a chimeric antibody containing the variable domain of human ACPA E4 and constant domains of mouse IgG2b the N-terminal Gln is posttranslationally modified to pyroglutamic acid residues not modeled are not visible in the electron density map 9606
515 5KVL 1 H Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) heavy chain Fab fragment 9606
516 5KVL 2 L Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) light chain 9606
517 5TDO 1 A, C anti-HER2 Fab Light Chain 9606
518 5TDO 2 B, D anti-HER2 Fab Heavy Chain 9606
519 8FAB 1 A, C IGG1-LAMBDA HIL FAB (LIGHT CHAIN) 9606
520 8FAB 2 B, D IGG1-LAMBDA HIL FAB (HEAVY CHAIN) 9606
521 5NHW 1 H anti-human ActRII Bimagrumab Fab heavy-chain C-terminal FLAG-His6 tag Fab heavy-chain 9606
522 5NHW 2 L anti-human ActRII Bimagrumab Fab light-chain Fab light-chain 9606
523 2ZPK 1 L, M IgG1-lambda P20.1 Fab (light chain) 10090
524 2ZPK 2 H, I IgG1-lambda P20.1 Fab (heavy chain) Variable and Constant region 10090
525 4DGV 1 H HCV1 Heavy Chain Fab 9606
526 4DGV 2 L HCV1 Light Chain 9606
527 6C5K 1 A, H IgG1 Fab Heavy Chain 10090
528 6C5K 2 B, L IgG1 Fab Light Chain (Kappa) 10090
529 2DQU 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
530 2DQU 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
531 5TH2 1 A, C cetuximab Fab, light chain 10090
532 5TH2 2 B, D cetuximab Fab, heavy chain 10090
533 5I8K 1 L HHH1 Fab Light chain 9606
534 5I8K 2 H HHH1 Fab Heavy chain 9606
535 4YDL 2 B, H HEAVY CHAIN OF ANTIBODY C38-VRC18.02 9606
536 4YDL 3 C, L LIGHT CHAIN OF ANTIBODY C38-VRC18.02 9606
537 3T4Y 1 A S25-2 FAB (IGG1K) LIGHT CHAIN 10090
538 3T4Y 2 B S25-2 FAB (IGG1K) HEAVY CHAIN 10090
539 1YNL 1 L Ig gamma light chain 10090
540 1YNL 2 H Ig gamma heavy chain 10090
541 5EPM 1 A, E Antibody Fab fragment heavy chain 10090
542 5EPM 2 B, F Antibody Fab fragment light chain 10090
543 2AJS 1 L Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 kappa light chain 10090
544 2AJS 2 H Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
545 3UMT 1 A scFv heavy chain and light chain 10090
546 3BZ4 1 A, C, E, G Fab F22-4 light chain 10090
547 3BZ4 2 B, D, F, H Fab F22-4 heavy chain 10090
548 4NUJ 1 A PGT152 light chain 9606
549 4NUJ 2 B PGT152 heavy chain 9606
550 3LIZ 2 L 4C3 monoclonal antibody Light Chain 10090
551 3LIZ 3 H 4C3 monoclonal antibody Heavy Chain 10090
552 1RUA 1 L immunoglobulin igg2a, light chain fab 10090
553 1RUA 2 H immunoglobulin igg2a, heavy chain fab 10090
554 3U2S 1 A, H PG9 heavy chain antigen-binding fragment 9606
555 3U2S 2 B, L PG9 light chain 9606
556 6PE7 1 H FAB Heavy Chain 9606
557 6PE7 2 L FAB Light chain 9606
558 5D6C 1 A, L 4497 antibody IgK (VL and CL) 9606
559 5D6C 2 B, H 4497 antibody IgG1 (VH and CH1) 9606
560 4GAG 1 H NEUTRALIZING ANTIBODY AP33 HEAVY CHAIN 10090
561 4GAG 2 L NEUTRALIZING ANTIBODY AP33 LIGHT CHAIN 10090
562 2R23 1 A Fab, antibody fragment (IgG1k), light chain 10090
563 2R23 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
564 4NUG 1 L PGT151 light chain 9606
565 4NUG 2 H PGT151 heavy chain 9606
566 3IU4 1 H chP3 Fab heavy chain 10090
567 3IU4 2 L chP3 Fab light chain 10090
568 3MNZ 2 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN mouse Fv,human Fc 10090
569 3MNZ 3 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN mouse Fv,human Fc 10090
570 6DC8 1 L IgG light chain 10090
571 6DC8 2 H IgG heavy chain 10090
572 3MLR 1 L Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab light chain 9606
573 3MLR 2 H Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab heavy chain 9606
574 1QYG 1 L FAB M82G2, LIGHT CHAIN 10090
575 1QYG 2 H FAB M82G2, HEAVY CHAIN 10090
576 6IAS 1 H Fab NKp46-1 heavy chain 32630
577 6IAS 2 L Fab NKp46-1 light chain 32630
578 1P7K 1 A, L antibody light chain FAB 10090
579 1P7K 2 B, H antibody heavy chain FAB 10090
580 6OBZ 1 A, H Heavy chain of FluA-20 Fab 9606
581 6OBZ 2 B, L Light chain of FluA-20 Fab, Immunoglobulin light chain 9606
582 3RVV 2 C 4C1 - light chain 10090
583 3RVV 3 D 4C1 - heavy chain 10090
584 5A2L 1 H SCFV-SM3 RESIDUES 6-115,20-129 10090
585 6GFE 2 L, M Immunoglobulin gamma-4 light chain 9606
586 3P0Y 2 H Fab DL11 heavy chain 9606
587 3P0Y 3 L Fab DL11 light chain 9606
588 4NPY 1 A, L germline PGT121 light chain Fab 9606
589 4NPY 2 B, H germline PGT121 heavy chain Fab 9606
590 6ANA 2 H LL2 Fab Heavy Chain 10090
591 6ANA 3 L LL2 Fab Light Chain 10090
592 5IBU 1 B, L 6652 Light Chain 9606
593 5IBU 2 G, H 6652 Heavy Chain 9606
594 5VPL 2 C 4C1 - LIGHT CHAIN 10090
595 5VPL 3 D 4C1 - HEAVY CHAIN 10090
596 6AOD 1 A FXIa Antibody FAB Light Chain 9606
597 6AOD 2 B FXIa Antibody FAB Heavy Chain 9606
598 5WCD 1 H VRC315 04-1D02 Fab Heavy chain 9606
599 5WCD 2 L VRC315 04-1D02 Fab Light chain 9606
600 2YPV 2 H FAB 12C1 10090
601 2YPV 3 L FAB 12C1 10090
602 4HH9 1 A, C Fab KE5, light chain KE5 Light chain 9606
603 4HH9 2 B, D Fab KE5, heavy chain KE5 Heavy Chain 9606
604 4JY5 1 L PGT122 light chain Fab 9606
605 4JY5 2 H PGT122 heavy chain Fab 9606
606 6ELE 1 A, H fAB heavy chain 9606
607 6ELE 2 B, L fAB light chain 9606
608 5UR8 1 A human immunoglobulin gamma, heavy chain Fd fragment 9606
609 5UR8 2 B human immunoglobulin gamma, kappa light chain 9606
610 6B5R 1 H CIS42 Fab Heavy chain 9606
611 6B5R 2 L CIS42 Fab Light chain 9606
612 3NAC 1 L Fab15 Mut7 light chain 9606
613 3NAC 2 H Fab15 Mut7 heavy chain 9606
614 5U5M 1 A MEMAB TRASTUZUMAB, LIGHT CHAIN 9606
615 5U5M 2 B MEMAB TRASTUZUMAB, HEAVY CHAIN 9606
616 2DQT 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
617 2DQT 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
618 1Q72 1 L Fab M82G2, Light chain 10090
619 1Q72 2 H Fab M82G2, Heavy chain 10090
620 4M1D 1 L, M Fab mAb 447-52D Light Chain 9606
621 4M1D 2 H, I Fab mAb 447-52D Heavy Chain 9606
622 6MNQ 2 H Ab DH727.2 heavy chain Fab fragment 9544
623 6MNQ 3 L Ab DH727.2 light chain 9544
624 1SEQ 1 L Monoclonal Antibody MNAC13 FAB Light Chain 10090
625 1SEQ 2 H Monoclonal Antibody MNAC13 FAB Heavy Chain 10090
626 4YHO 1 H aDabi-Fab3 heavy chain 9606
627 4YHO 2 L aDabi-Fab3 light chain 9606
628 6FZR 1 H scFv-SM3 Special processing instructions: Although this structure is a ScFv, please follow the same numbering as shown in PDB entry 5OWP. 10090
629 6NMT 1 A Fab 3 anti-SIRP-alpha antibody Variable Light Chain 9606
630 6NMT 2 B Fab 3 anti-SIRP-alpha antibody Variable Heavy Chain 9606
631 2R1W 1 A Fab, antibody fragment (IgG1k), light chain 10090
632 2R1W 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
633 3MO1 1 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
634 3MO1 2 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
635 4DGY 1 H HCV1 Heavy Chain Fab 9606
636 4DGY 2 L HCV1 Light Chain 9606
637 5EN2 1 A GD01 heavy chain 10090
638 5EN2 2 B GD01 light chain 10090
639 3T77 1 A S25-2 FAB (IGG1K) light chain 10090
640 3T77 2 B S25-2 FAB (IGG1K) heavy chain 10090
641 6P4Y 1 H 4A10 Fab heavy chain 10090
642 6P4Y 2 L 4A10 Fab light chain 10090
643 3MXW 2 L 5E1 light chain 9606
644 3MXW 3 H 5E1 heavy chain 9606
645 2V7N 1 A, C, E, G IMMUNOGLOBULIN LIGHT CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-255 32630
646 2V7N 2 B, D, F, H IMMUNOGLOBULIN HEAVY CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-259 32630
647 3EO9 1 L Efalizumab Fab fragment, light chain 9606
648 3EO9 2 H Efalizumab Fab fragment, heavy chain 9606
649 4ALA 2 H FAB 2H12 HEAVY CHAIN 10090
650 4ALA 3 L FAB 2H12 LIGHT CHAIN 10090
651 6N35 1 K, L Fab 2G12 light chain 9606
652 6N35 2 H, M Fab 2G12 heavy chain 9606
653 4F33 1 A, C, E, G MORAb-009 FAB light chain 10090
654 4F33 2 B, D, F, H MORAb-009 FAB heavy chain 10090
655 3C6S 1 A, C, E, G Fab F22-4 light chain 10090
656 3C6S 2 B, D, F, H Fab F22-4 heavy chain 10090
657 5WUV 1 L light chain 9606
658 5WUV 2 H heavy chain 9606
659 4Z8F 1 H S1-15 Fab (IgG2b) heavy chain 10090
660 4Z8F 2 L S1-15 Fab (IgG2b kappa) light chain 10090
661 3OKL 1 A S25-39 Fab (IgG1k) light chain 10090
662 3OKL 2 B S25-39 Fab (IgG1k) heavy chain 10090
663 4JM4 1 H PGT 135 Heavy Chain Fab 9606
664 4JM4 2 L PGT 135 Light Chain Fab 9606
665 2HWZ 1 L Immunoglobulin Fab light chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
666 2HWZ 2 H Immunoglobulin Fab heavy chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
667 5YE4 1 A, C 1A9D7 VH CH1 chain 10090
668 5YE4 2 B, D 1A9D7 L chain 10090
669 6B0G 1 C 1245 Antibody, Light Chain 9606
670 6B0G 2 D 1245 Antibody, Heavy Chain 9606
671 5TDP 1 A, C anti-HER2 Fab Light Chain 9606
672 5TDP 2 B, D anti-HER2 Fab Heavy Chain 9606
673 1ZEA 1 L monoclonal anti-cholera toxin IGG1 KAPPA antibody, L chain 10090
674 1ZEA 2 H monoclonal anti-cholera toxin IGG1 KAPPA antibody, H chain 10090
675 6BAH 1 A Trastuzumab Fab light chain,Immunoglobulin kappa constant 10090
676 6BAH 2 B Trastuzumab Fab heavy chain,IGH@ protein 10090
677 6D0X 1 A 2140 Antibody, heavy chain 9606
678 6D0X 2 B 1210 Antibody, light chain 9606
679 6BE4 1 H Fab (F598) Heavy Chain 9606
680 6BE4 2 L Fab(F598) Light Chain 9606
681 5TPP 1 L DH270.5 Fab heavy chain 9606
682 5TPP 2 H DH270.5 Fab light chain 9606
683 5L88 1 H Anti-afamin antibody N14, Fab fragment, heavy chain 10090
684 5L88 2 L Anti-afamin antibody N14, Fab fragment, light chain 10090
685 1Q9W 1 A, C S45-18 Fab (IgG1k) light chain Fab1 Light chain kappa 10090
686 1Q9W 2 B, D S45-18 Fab (IgG1k) heavy chain Fab1 Heavy chain g1 10090
687 4P3C 1 H Heavy Chain Fab fragment of antibody LEM-2/15 MT1-MMP V-B loop 10090
688 4P3C 2 L Light Chain Fab fragment of antibody LEM-2/15 10090
689 1L7I 1 L chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence light chain (residues 1-214) 9606
690 1L7I 2 H chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence heavy chain (residues 1-216) 9606
691 1JPT 1 L immunoglobulin Fab D3h44, light chain Fab fragment 9606
692 1JPT 2 H immunoglobulin Fab D3H44, heavy chain Fab fragment 9606
693 1AQK 1 L FAB B7-15A2 IMMUNOGLOBULIN HUMAN FAB FAB 9606
694 1AQK 2 H FAB B7-15A2 IMMUNOGLOBULIN HUMAN FAB FAB 9606
695 5TL5 1 L M2177 LIGHT CHAIN 10090
696 5TL5 2 H M2177 HEAVY CHAIN 10090
697 2FX7 1 L Fab 4E10 Light Chain 9606
698 2FX7 2 H Fab 4E10 Heavy Chain 9606
699 6O39 1 A Antibody F2.I Fab, Light chain 9606
700 6O39 2 B Antibody F2.I Fab, Heavy chain 9606
701 5Y9K 1 L belimumab light chain 9606
702 5Y9K 2 H belimumab heavy chain 9606
703 4DTG 1 L Humanized recombinant FAB fragment, FAB 2021, of a murine antibody, light chain 9606
704 4DTG 2 H Humanized recombinant FAB fragment, FAB 2021, of a murine antibody, heavy chain 9606
705 5CSZ 1 A, H GANTENERUMAB FAB FRAGMENT HEAVY CHAIN FAB 9606
706 5CSZ 2 B, L GANTENERUMAB FAB FRAGMENT LIGHT CHAIN FAB 9606
707 6GLW 2 C, H Fab 1D11 - Heavy chain 9844
708 6GLW 3 D, L Fab 1D11 - Light chain 9844
709 3WFH 1 A mAb Fab H fragment 10090
710 3WFH 2 B mAb Fab L fragment 10090
711 4K3D 1 H, I BOVINE ANTIBODY WITH ULTRALONG CDR H3, HEAVY CHAIN 9913
712 4K3D 2 L, M BOVINE ANTIBODY WITH ULTRALONG CDR H3, LIGHT CHAIN 9913
713 4H8W 2 H FAB HEAVY CHAIN OF ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ANTIBODY N5-I5 9606
714 4H8W 3 L FAB LIGHT CHAIN OF ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ANTIBODY N5-I5 9606
715 3HNT 1 H CS-35 Fab Heavy Chain Heavy Chain 10090
716 3HNT 2 L CS-35 Fab Light Chain Light Chain 10090
717 6GKU 2 H Fab 6F5 - Heavy Chain 9844
718 6GKU 3 L Fab 6F5 - Light chain 9844
719 1WEJ 1 L E8 ANTIBODY IGG1 KAPPA MOUSE MONOCLONAL ANTIBODY FAB 10090
720 1WEJ 2 H E8 ANTIBODY IGG1 KAPPA MOUSE MONOCLONAL ANTIBODY FAB 10090
721 5VPG 2 C FAB 4C1 - LIGHT CHAIN 10090
722 5VPG 3 D FAB 4C1 - HEAVY CHAIN 10090
723 5HI4 2 C, H CAT-2000 FAB heavy chain 9606
724 5HI4 3 D, L CAT-2000 FAB light chain 9606
725 5NUZ 1 A, H eOD01 heavy chain Fab fragment (domains: variable heavy and constant heavy 1) Fab fragment (domains: variable heavy and constant heavy 1) 10090
726 5NUZ 2 B, L eOD01 light chain Fab fragment (domains: variable light and constant light) Fab fragment (domains: variable light and constant light) 10090
727 6QKD 1 H, I, J, K FAB HEAVY CHAIN 9844
728 6QKD 2 L, M, O, T FAB LIGHT CHAIN 9844
729 5FCU 2 H JR4 FAB HEAVY CHAIN 9544
730 5FCU 3 L JR4 FAB LIGHT CHAIN 9544
731 3RVW 2 C 4C1 - light chain 10090
732 3RVW 3 D 4C1 - heavy chain 10090
733 5DD3 1 H ANTI-HIV ANTIBODY DH570.4 FAB HEAVY CHAIN 9544
734 5DD3 2 L ANTI-HIV ANTIBODY DH570.4 FAB LIGHT CHAIN 9544
735 5XKU 2 B HNIgGA6 light chain 9606
736 5XKU 3 C HNIgGA6 heavy chain 9606
737 3D85 1 A FAB of antibody 7G10, light chain light chain 9606
738 3D85 2 B FAB of antibody 7G10, heavy chain heavy chain 9606
739 4Z95 1 H S1-15 Fab (IgG2b) heavy chain 10090
740 4Z95 2 L S1-15 Fab (IgG2b) light chain 10090
741 5HI5 2 C, H CAT-2000 FAB heavy chain 9606
742 5HI5 3 D, L CAT-2000 light chain 9606
743 5JO5 1 A, C, E, H 10E8 gHV 9606
744 5JO5 2 B, D, F, L 10E8 gLV 9606
745 5L9D 1 H MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA HEAVY CHAIN 10090
746 5L9D 2 L MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA LIGHT CHAIN 10090
747 5CCK 1 H Antibody 3BC315 Fab heavy chain 9606
748 5CCK 2 L Antibody 3BC315 Fab light chain 9606
749 6RNN 1 C, L Immunoglobulin light chain 10090
750 6GXX 1 H FAB 1D9 heavy chain 10090
751 6GXX 2 L FAB 1D9 light chain 10090
752 5I76 1 A, C FM318_light_chain 1383439
753 5I76 2 B, D FM318_heavy_cahin 1383439
754 1KCV 1 L PC282 IMMUNOGLOBULIN light chain 10090
755 1KCV 2 H PC282 IMMUNOGLOBULIN heavy chain 10090
756 1FLR 1 L 4-4-20 (IG*G2A=KAPPA=) FAB FRAGMENT 10090
757 1FLR 2 H 4-4-20 (IG*G2A=KAPPA=) FAB FRAGMENT 10090
758 6MTT 1 L Antibody VRC46.01 Fb light chain 9606
759 6MTT 2 H Antibody VRC46.01 Fab heavy chain 9606
760 5I18 1 L FAB LIGHT CHAIN 9606
761 5I18 2 H FAB HEAVY CHAIN 9606
762 6QB3 2 X scFv55 9606
763 4JN1 1 H anti-dabigatran Fab1, heavy chain 10090
764 4JN1 2 L anti-dabigatran Fab1, light chain 10090
765 6UGS 1 A, H Infliximab (Remicade) Fab Heavy Chain 9606
766 6UGS 2 B, L Infliximab (Remicade) Fab Light Chain 9606
767 4P3D 1 A, H Heavy Chain Fab fragment of antibody LEM-2/15 10090
768 4P3D 2 B, L Light Chain Fab fragment of antibody LEM-2/15 10090
769 4G5Z 1 H canakinumab antibody fragment heavy chain 9606
770 4G5Z 2 L canakinumab antibody fragment light chain 9606
771 6HKG 1 A FISW84 Fab Fragment Heavy Chain 9606
772 6HKG 2 B FISW84 Fab Fragment Light Chain 9606
773 6HKG 3 C FISW84 Fab Fragment Heavy Chain 9606
774 3TNM 1 A, H Fab heavy chain of human anti-HIV-1 Env antibody A32 9606
775 3TNM 2 B, L Fab light chain of human anti-HIV-1 Env antibody A32 9606
776 2OK0 2 L Fab ED10 light chain 10090
777 2OK0 3 H Fab ED10 heavy chain 10090
778 3SOB 1 L antibody light chain 9606
779 3SOB 3 H antibody heavy chain 9606
780 6B5M 1 H CIS43 Fab Heavy chain 9606
781 6B5M 2 L CIS43 Fab Light chain 9606
782 5AWN 1 H Heavy chain of 3BC176 Fab 9606
783 5AWN 2 L Light chain of 3BC176 Fab 9606
784 4ZFO 2 L J22.9-xi Fab, Light Chain Fab Light Chain fragment of anti-BCMA antibody J22.9-xi 10090
785 4ZFO 3 A, H J22.9-xi Fab, Heavy Chain Fab Heavy Chain fragment of anti-BCMA antibody J22.9-xi 10090
786 4ZFO 4 B J22.9-xi Fab, Light Chain Fab Light Chain fragment of anti-BCMA antibody J22.9-xi 10090
787 4G6M 2 H heavy chain of gevokizumab antibody binding fragment 10090
788 4G6M 3 L light chain of gevokizumab antibody binding fragment 10090
789 5DR5 1 H AbD09097 Fab heavy chain The Fab heavy chain contains a C-terminal Myc- and hexahistidine extension preceded by thrombin peptidase recognition sequence to facilitate detection and purification 9606
790 5DR5 2 L AbD09097 Fab light chain 9606
791 6MG5 1 A, B Light chain JTO 9606
792 2IH3 1 A FAB Heavy Chain 10090
793 2IH3 2 B FAB Light Chain 10090
794 4KQ3 1 L CNTO3186 light chain Fab 9606
795 4KQ3 2 H CNTO3186 heavy chain Fab 9606
796 6AQ7 2 H POM6 FAB Heavy CHAIN 10090
797 6AQ7 3 L POM6 FAB light CHAIN 10090
798 4JFX 1 A, L Fab light chain 9606
799 4JFX 2 B, H Fab heavy chain 9606
800 3SGE 1 I, L Light Chain 10090
801 3SGE 2 H, J Heavy Chain 10090
802 1BM3 1 L IMMUNOGLOBULIN OPG2 FAB, CONSTANT DOMAIN CONSTANT DOMAIN 10090
803 1BM3 2 H IMMUNOGLOBULIN OPG2 FAB, VARIABLE DOMAIN VARIABLE DOMAIN 10090
804 4TUJ 1 A, C Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
805 4TUJ 2 B, D Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
806 2VXQ 2 H FAB H CHAIN OF THE FAB FRAGMENT COMPOSED OF THE IGE VARIABLE DOMAIN AND IGG CONSTANT DOMAIN 9606
807 2VXQ 3 L FAB L CHAIN OF THE FAB FRAGMENT COMPOSED OF THE IGE VARIABLE DOMAIN AND IGG CONSTANT DOMAIN 9606
808 2XWT 1 A THYROID BLOCKING HUMAN AUTOANTIBODY K1-70 HEAVY CHAIN FAB FRAGMENT HEAVY CHAIN, RESIDUES 1-229 9606
809 2XWT 2 B THYROID BLOCKING HUMAN AUTOANTIBODY K1-70 LIGHT CHAIN FAB FRAGMENT LIGHT CHAIN, RESIDUES 1-213 9606
810 5FHB 1 H Antibody 100 Fab heavy chain 9606
811 5FHB 2 L Antibody 100 Fab light chain 9606
812 3HZM 1 A S73-2 Fab (IgG1k) light chain 10090
813 3HZM 2 B S73-2 Fab (IgG1k) heavy chain 10090
814 1JGU 1 L Antibody Light Chain 10090
815 1JGU 2 H Antibody Heavy Chain 10090
816 4I77 1 H Lebrikizumab heavy chain Fab 9606
817 4I77 2 L Lebrikizumab light chain Fab 9606
818 4OCR 1 L CAP256-VRC26.01 light chain Fab 9606
819 4OCR 2 H CAP256-VRC26.01 heavy chain Fab 9606
820 4O4Y 1 L 2095-2 light chain SEE REMARK 999 9986
821 4O4Y 2 H 2095-2 heavy chain 9986
822 5OBF 1 H fAb Heavy chain 10090
823 5OBF 2 L fAb Light chain 10090
824 6QNK 1 A, C FAB light chain 10090
825 6QNK 2 B, D FAB heavy chain 10090
826 5LGH 1 H MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA HEAVY CHAIN IGG1-KAPPA HEAVY CHAIN, 1-214 10090
827 5LGH 2 L MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA LIGHT CHAIN IGG1-KAPPA LIGHT CHAIN, 1-214 10090
828 1UZ8 1 A, L IGG FAB (IGG3, KAPPA) LIGHT CHAIN 291-2G3-A FAB FRAGMENT LIGHT CHAIN, RESIDUES 1-212 10090
829 1UZ8 2 B, H IGG FAB (IGG3, KAPPA) HEAVY CHAIN 291-2G3-A FAB FRAGMENT HEAVY CHAIN, RESIDUES 1-213 10090
830 1DQQ 1 A, C ANTI-LYSOZYME ANTIBODY HYHEL-63 (LIGHT CHAIN) FAB FRAGMENT 10090
831 1DQQ 2 B, D ANTI-LYSOZYME ANTIBODY HYHEL-63 (HEAVY CHAIN) FAB FRAGMENT 10090
832 5L7X 1 H Mouse Antibody Fab Fragment, IgG1-kappa Heavy Chain IgG1-kappa heavy chain, 1-214 10090
833 5L7X 2 L Mouse Antibody Fab Fragment, IgG1-kappa Light Chain IgG1-kappa light chain, 1-214 10090
834 5V6M 1 L Light chain of Fab fragment of rabbit anti-HIV1 gp120 V3 mAb 10A3 9986
835 5V6M 2 H Heavy chain of Fab fragment of rabbit anti-HIV1 gp120 V3 mAb 10A3 9986
836 5MHE 1 L Fab-fragment 10090
837 5MHE 2 H Fab-fragment 10090
838 5YFI 1 L Light chain of Fab fragment 10090
839 5YFI 2 H Heavy chain of Fab fragment 10090
840 4GLR 2 H, J anti-ptau heavy chain heavy chain 9031
841 4GLR 3 I, K anti-ptau light chain light chain 9031
842 5WK3 1 P, R, T, V M116 LIGHT CHAIN 9606
843 5WK3 2 Q, S, U, W M116 HEAVY CHAIN FD 9606
844 6MTR 1 H Antibody VRC43.01 Fab heavy chain 9606
845 6MTR 2 L Antibody VRC43.01 Fab light chain 9606
846 4HJG 1 A Trastuzumab light chain 9606
847 4HJG 2 B Trastuzumab heavy chain 9606
848 5OWP 1 H Ig heavy chain V-III region J606,Ig lambda-1 chain V region H2020 10090
849 4M43 1 L Fragment antigen-binding 523-11 light chain 10090
850 4M43 2 H Fragment antigen-binding 523-11 heavy chain 10090
851 5I30 1 L Fab PL-2 light chain 10090
852 5I30 2 H Fab PL-2 heavy chain 10090
853 3HC0 1 A, H IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
854 3HC0 2 B, L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
855 3BKC 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
856 3BKC 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
857 6CT7 1 B, L BIIB054 Fab light chain 9606
858 6CT7 2 A, H BIIB054 Fab heavy chain 9606
859 3FN0 1 L Fab Z13e1 light chain 9606
860 3FN0 2 H Fab Z13e1 heavy chain 9606
861 5X5X 1 H Fd chain of anti-osteocalcin antibody KTM219 10090
862 5X5X 2 L L chain of anti-osteocalcin antibody KTM219 10090
863 4YHI 1 A, H aDabi-Fab2a heavy chain 9606
864 4YHI 2 B, L aDabi-Fab2a light chain 9606
865 5NYX 1 H, M, O HEAVY CHAIN CHAIN H AND O ARE TWO SEPARATE POLYPEPTIDE CHAINS. fab heavy chains. The sequence provided contains the cleavable strep tag that has been removed prior to crystallisation 9606
866 5NYX 2 L, N, P LIGHT CHAIN fab light chain 9606
867 5YUP 1 H the heavy chain of the Fab fragment of FVIIa antibody mAb4F5 10090
868 5YUP 2 L the light chain of the Fab fragment of FVIIa antibody mAb4F5 10090
869 4OSU 1 H SM5-1 Fab Heavy Chain 9606
870 4OSU 2 L SM5-1 Fab Light Chain 9606
871 3MXV 1 L fab fragment of anti-Shh 5E1 mouse/human chimera, light chain 10090
872 3MXV 2 H fab fragment of anti-Shh 5E1 mouse/human chimera, heavy chain 10090
873 5IFA 1 H VRC01c-HuGL2 Fab heavy chain 9606
874 5IFA 2 L VRC01c-HuGL2 Fab light chain 9606
875 1T2Q 1 L Fab NNA7 Heavy Chain 10090
876 1T2Q 2 H Fab NNA7 Light Chain 10090
877 6ELJ 1 A, H fAB heavy chain 9606
878 6ELJ 2 B, L fAB light chain 9606
879 4G6K 1 H heavy chain of gevokizumab antibody binding fragment 10090
880 4G6K 2 L light chain of gevokizumab antibody binding fragment 10090
881 4MAU 1 L C2244 light chain SEE REMARK 999 10090
882 4MAU 2 H C2244 heavy chain FD, SEE REMARK 999 10090
883 3LEX 1 A, H 11f10 Antibody Heavy Chain 10090
884 3LEX 2 B, L 11f10 Antibody Light Chain 10090
885 6B0W 1 L 1710 antibody, light chain 9606
886 6B0W 2 H 1710 antibody, heavy chain 9606
887 6DC7 1 L, M Fab light chain 10090
888 6DC7 2 H, I Fab heavy chain 10090
889 5VH4 1 A, H Infliximab Fab Heavy Chain 10090
890 5VH4 2 B, L Infliximab Fab Light Chain 10090
891 6NOU 1 A scFv derived from ixekizumab 9606
892 5DQD 1 L S55-5 Fab (IgG1 kappa) light chain 10090
893 5DQD 2 H S55-5 Fab (IgG1) heavy chain 10090
894 5DT1 1 H Fab Heavy chain of broadly neutralizing antibody VRC26.25 9606
895 5DT1 2 L Fab Light chain of broadly neutralizing antibody VRC26.25 9606
896 4ONF 1 H 3D6 FAB ANTIBODY HEAVY CHAIN 10090
897 4ONF 2 L 3D6 FAB ANTIBODY LIGHT CHAIN 10090
898 1OPG 1 L OPG2 FAB (LIGHT CHAIN) 9606
899 1OPG 2 H OPG2 FAB (HEAVY CHAIN) 9606
900 1JPS 1 L immunoglobulin Fab D3H44, light chain Fab fragment 9606
901 1JPS 2 H immunoglobulin Fab D3H44, heavy chain Fab fragment 9606
902 5NPJ 1 A, B Single chain variable fragment of the non-neutralizing antibody DAO5